Skip to main content
. 2023 Apr 26;113(2):304–313. doi: 10.1093/ajcn/nqaa338

TABLE 4.

Interaction models for prenatal methylmercury exposure against child outcomes at 7 years of age with PUFA status

Outcome n Interaction with n-3, MeHg slope1 Interaction with n-6, MeHg slope1 Interaction with n-6:n3 ratio, MeHg slope1
n-3 PUFA lowest fertile Beta, SE, P n-3 PUFA middle tertile Beta, SE, P n-3 PUFA highest tertile Beta, SE, P Hg by n-3 interaction P value P n-6 PUFA lowest tertile Beta, SE, P n-6 PUFA middle tertile Beta, SE, P n-6 PUFA highest tertile Beta, SE, P Hg by n-6 interaction P value P n-6/n-3 PUFA lowest tertile Beta, SE, P n-6/n-3 PUFA middle tertile Beta, SE, P n-6/n-3 PUFA highest tertile Beta, SE, P Hg by n-6/n-3 ratio interaction P value P
Log, Trailmaking time A 1132 0.00, 0.01, P = 0.88 0.00, 0.01, P = 0.96 0.01, 0.01, P = 0.11 0.49 −0.01, 0.01, P = 0.27 0.02, 0.01, P = 0.02 0.01, 0.01, P = 0.25 0.03 −0.00, 0.01, P = 0.80 0.00, 0.01, P = 0.48 0.02, 0.01, P = 0.04 0.18
Square root, BNT 1229 0.00, 0.01, P = 0.82 0.01, 0.01, P = 0.19 0.00, 0.01, P = 0.48 0.78 0.00, 0.01, P = 0.55 0.00, 0.01, P = 0.64 0.01, 0.01, P = 0.12 0.70 0.01, 0.01, P = 0.31 0.00, 0.01, P = 0.52 0.01, 0.01, P = 0.37 0.97
CELF-5 total 1200 −0.22, 0.25, P = 0.37 0.29, 0.21, P = 0.18 −0.28, 0.21, P = 0.18 0.12 −0.04, 0.21, P = 0.86 0.03, 0.23, P = 0.90 −0.15, 0.23, P = 0.51 0.85 0.01, 0.20, P = 0.95 −0.20, 0.23, P = 0.37 −0.05, 0.25, P = 0.85 0.76
CELF-5 FD 1224 −0.01, 0.06, P = 0.86 0.01, 0.06, P = 0.81 −0.09, 0.05, P = 0.10 0.38 −0.06, 0.05, P = 0.25 −0.01, 0.06, P = 0.89 −0.02, 0.06, P = 0.79 0.77 −0.06, 0.05, P = 0.21 −0.07, 0.06, P = 0.26 0.06, 0.07, P = 0.36 0.26
CELF-5 LC^2 1231 −0.98, 1.46, P = 0.50 0.51, 1.28, P = 0.69 −0.39, 1.26, P = 0.76 0.73 −0.68, 1.23, P = 0.58 −0.41, 1.40, P = 0.77 0.65, 1.35, P = 0.63 0.75 1.36, 1.17, P = 0.25 −2.39, 1.34, P = 0.08 −0.08, 1.52, P = 0.96 0.11
CELF-5 RS 1219 −0.13, 0.12, P = 0.26 0.14, 0.10, P = 0.16 −0.11, 0.10, P = 0.27 0.11 −0.01, 0.10, P = 0.90 −0.03, 0.11, P = 0.78 −0.03, 0.11, P = 0.77 0.99 −0.01, 0.09, P = 0.96 −0.06, 0.11, P = 0.55 −0.04, 0.12, P = 0.74 0.92
CELF-5 SC 1222 −1.16, 2.17, P = 0.59 3.31, 1.89, P = 0.08 −1.86, 1.85, P = 0.32 0.11 1.60, 1.83, P = 0.38 0.61, 2.07, P = 0.77 −2.08, 2.00, P = 0.30 0.38 1.12, 1.74, P = 0.52 −0.77, 1.99, P = 0.70 −0.77, 2.26, P = 0.73 0.71
Square root, CELF-5 USP 1215 −0.00, 0.01, P = 0.78 −0.00, 0.01, P = 0.94 0.00, 0.01, P = 0.97 0.97 −0.00, 0.01, P = 0.72 0.01, 0.01, P = 0.33 −0.01, 0.01, P = 0.39 0.40 0.00, 0.01, P = 0.68 −0.01, 0.01, P = 0.52 −0.00, 0.01, P = 0.86 0.75
Square root, CBCL total 1218 −0.02, 0.03, P = 0.58 −0.00, 0.02, P = 0.99 0.00, 0.02, P = 0.88 0.86 −0.02, 0.02, P = 0.33 0.04, 0.03, F= 0.18 −0.02, 0.03, P = 0.55 0.21 −0.02, 0.02, P = 0.36 0.00, 0.03, P = 0.92 0.02, 0.03, P = 0.58 0.58
KBIT word knowledge 1233 −0.20, 0.12, P = 0.10 −0.07, 0.11, P = 0.49 0.01, 0.11, P = 0.93 0.42 −0.19, 0.10, P = 0.06 −0.04, 0.12, P = 0.72 0.04, 0.11, P = 0.71 0.28 −0.07, 0.10, P = 0.49 −0.07, 0.11, P = 0.53 −0.12, 0.13, P = 0.36 0.95
KBIT matrices 1229 −0.01, 0.07, P = 0.91 0.05, 0.07, P = 0.47 0.01, 0.06, P = 0.94 0.84 0.03, 0.06, P = 0.69 −0.01, 0.07, P = 0.90 0.05, 0.07, P = 0.51 0.85 0.02, 0.06, P = 0.79 0.03, 0.07, P = 0.69 0.01, 0.08, P = 0.92 0.98
WJ-III applied problems ^2 1225 −1.44, 2.51, P = 0.57 1.91, 2.19, P = 0.38 −0.04, 2.16, P = 0.99 0.59 −0.19, 2.11, P = 0.93 −2.30, 2.42, P = 0.34 2.70, 2.32, P = 0.24 0.31 0.09, 2.01, P = 0.97 −0.60, 2.31, P = 0.80 0.76, 2.62, P = 0.77 0.93
WJ-III letter word 1224 −0.17, 0.34, P = 0.62 −0.18, 0.30, P = 0.55 −0.70, 0.30, P = 0.02. 0.36 −0.33, 0.29, P = 0.26 −0.31, 0.33, P = 0.34 −0.46, 0.32, P = 0.15 0.94 −0.31, 0.28, P = 0.26 −0.82, 0.32, P = 0.01 0.05, 0.36, P = 0.88 0.17
FT dominant hand 1222 0.06, 0.08, P = 0.43 0.04, 0.07, P = 0.57 −0.08, 0.07, P = 0.24 0.31 0.02, 0.07, P = 0.81 0.03, 0.07, P = 0.71 −0.03, 0.07, P = 0.64 0.82 0.03, 0.06, P = 0.62 −0.10, 0.07, F= 0.16 0.09, 0.08, P = 0.26 0.17
FT nondominant hand 1223 −0.06, 0.07, P = 0.39 0.08, 0.06, P = 0.17 −0.14, 0.06, P = 0.02 0.03 0.02, 0.06, P = 0.75 −0.01, 0.07, P = 0.85 −0.12, 0.06, P = 0.07 0.27 −0.04, 0.06, P = 0.51 −0.04, 0.06, P = 0.51 −0.02, 0.07, P = 0.82 0.96
Square root, SCQ total 1227 −0.01, 0.01, P = 0.29 −0.01, 0.01, P = 0.14 −0.01, 0.01, P = 0.27 0.97 −0.02, 0.01, P = 0.03 −0.00, 0.01, P = 0.67 −0.01, 0.01, P = 0.34 0.50 −0.03, 0.01, P < 0.005 −0.00, 0.01, P = 0.99 −0.01, 0.01, P = 0.65 0.13
Square root, SRS-2 total 1235 −0.00, 0.02, P = 0.91 −0.00, 0.02, P = 0.82 0.00, 0.02, P = 0.88 0.96 −0.01, 0.02, P = 0.53 0.01, 0.02, P = 0.75 0.00, 0.02, P = 0.91 0.78 −0.01, 0.02, P = 0.36 0.01, 0.02, P = 0.72 0.00, 0.02, P = 0.82 0.62

Regression analysis was performed for each outcome separately. Beta values are estimated regression coefficients. B and SE values are expressed as change in outcome per interquartile range increase in exposure (3.75 ppm). The P values have not been adjusted for multiple comparisons. P values are considered statistically significant when P < 0.0029. Abbreviations: BNT, Boston Naming Test; CBCL, Child Behavior Checklist; CELF-5, Clinical Evaluation of Language Fundamentals–5; FD, following directions; FT, finger tapping; KBIT-2, Kaufman Brief Intelligence Test 2; LC, linguistic concepts; MeHg, methylmercury; RS, recalling sentences; SC, sentence comprehension; SCQ, Social Communication Questionnaire; SRS-2, Social Responsiveness Scale 2; USP, understanding spoken paragraphs; WJ-III, Woodcock-Johnson Test of Scholastic Achievement–III.

1

Models shown were adjusted for maternal age, maternal IQ, child age, child sex, Hollingshead socioeconomic status, and family status. CELF-5 outcomes are also adjusted for interviewer. Models including the n-3 by MeHg interaction were additionally adjusted for n-6 PUFA, and models including the n-6 by MeHg interaction were additionally adjusted for n-3 PUFA. Serum concentrations for the tertiles were as follows: high n-3 PUFAs, >0.308 mg/mL; medium n-3 PUFAs, 0.228–0.308 mg/mL; low n-3 PUFAs, <0.228 mg/mL; high n-6 PUFAs, >1.208 mg/mL; medium n-6 PUFAs, 0.962–1.208 mg/mL; low n-6 PUFAs, <0.962 mg/mL; high n-6/n-3, >4.496; medium n-6/n-3, 3.523–4.496; low n-6/n-3, <3.523.